Introduction
Dysembryoplastic neuroepithelial tumor (DNET) is a recently described, morphologically unique low-grade brain tumor of the pediatric group. It is included in WHO 2007 classification as neuronal and mixed neuronal-glial tumor. Incidence among all neuroepithelial tumors is 1.2% in patients under 20 years and 0.2% in age over 20 years. The importance of identifying this particular entity is that it is a surgically curable, nonrecurring tumor with an excellent prognosis.
Case Report
An 8-year-old male child presented with intractable seizures since 3 years which were refractory to antiepileptic drugs. There were no neurological deficits, and other systemic examination was normal. Magnetic resonance imaging showed a cystic space occupying lesion divided by multiple septa in the cortex ("pseudo-polycystic appearance") of dysembryogenetic origin, but debate still continues about their true nature. The tumor is characterized by supratentorial intracortical location, multinodular architecture, and heterogenous cellular composition occurring in young patients with medically intractable epileptic seizures. Although temporal lobe is the most common location, tumors in frontal and parietal locations, parieto-occipital location, [2] and pontomesencephalic junction [3] have been reported.
The principal differential diagnosis is oligodendrogliomas and gangliogliomas. Oligodendroglioma is located in cortex and white matter. The absence of floating neurons with GFAP and synaptophysin negativity can help in ruling out the oligodendroglioma. Gangliogliomas are, however, positive for GFAP and synaptophysin but radiologically present as a cystic mass with mural nodule. They show neoplastic ganglion cells and perivascular lymphocytic infiltrate. Although many cases of DNETs have been reported, only 2 of them until date have turned malignant, one of which occurred after radiation therapy.
[4]
Conclusion
DNETs are clinically benign, nonrecurring tumor of young adults. It may assume the guises of oligodendroglioma, oligoastrocytoma, pilocytic astrocytoma, and ganglioglioma.
Surgery forms the mainstay of treatment. Careful observation of entire tissue sample is necessary before giving the diagnosis of its differentials, especially when the architecture is distorted due to inadvertent surgical aspiration or fragmentation due to fixation. When recognized the need for adjuvant radiotherapy and chemotherapy is obviated. Hence, identification of this tumor has therapeutic and prognostic implications because aggressive therapy can be avoided, sparing the young patients from deleterious long-term effects of radio and chemotherapy.
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